v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 4,111 $ 268
Premiums receivable 307 766
Deferred policy acquisition costs 35 102
Operating lease right-of-use assets 62 43
Prepayment and other assets 132 150
Property and equipment, net 14 16
Total assets 20,372 8,053
Liabilities:    
Reserve for losses and loss adjustment expenses 91 91
Notes payable to noteholders 118 118
Premium payable 31
Unearned premiums reserve 316 926
Losses payable 73 73
Operating lease liabilities 62 43
Accounts payable and other liabilities 329 309
Total liabilities 1,020 1,560
Mezzanine Equity    
Total Mezzanine equity 12,578 518
Shareholders’ equity:    
Ordinary share capital, (par value $0.001, 500,000,000 shares authorized; 8,101,374 and 7,664,122 shares issued and outstanding) 6 6
Additional paid-in capital 38,516 38,047
Accumulated Deficit (31,936) (32,137)
Total Oxbridge shareholders’ equity 6,586 5,916
Non-controlling interests 188 59
Total shareholders’ equity 6,774 5,975
Total liabilities, mezzanine and shareholders’ equity 20,372 8,053
Cat Re Token Program [Member]    
Assets    
Restricted cash and cash equivalents 3,691 6,708
HCI 2026 Token Program [Member]    
Assets    
Restricted cash and cash equivalents 12,020
Cat Re / T20 / T42 tokenholders [Member]    
Mezzanine Equity    
Total Mezzanine equity 558 518
HCI 2026 Series A Tokens [Member]    
Mezzanine Equity    
Total Mezzanine equity 3,600
HCI 2026 Series B Tokens [Member]    
Mezzanine Equity    
Total Mezzanine equity 4,900
HCI 2026 Series C Tokens [Member]    
Mezzanine Equity    
Total Mezzanine equity $ 3,520